还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

1 a/ w& o5 ~- s                               
登录/注册后可看大图

# N  c) ~  f7 I; }, {请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

% \/ y- ~. a1 t) k, P$ [3 T可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  

/ }$ ]8 T# S$ U; b
8 w# s+ q1 E, h3 l' G+ g* u5 ?Sub-category:
Molecular Targets


6 A. N% k/ b3 Z" E% l  c7 P+ V, {: YCategory:
Tumor Biology
1 F8 [6 D1 D+ f) R+ I

& c' x# V) F( V6 {1 ~% q( I+ B' p. DMeeting:
2011 ASCO Annual Meeting
4 @4 p7 x: h, a% L; \3 W& d; |

Session Type and Session Title:
' }) N4 E+ i6 R9 [& KPoster Discussion Session, Tumor Biology


' w" `6 @1 K, H1 u+ bAbstract No:
10517
' p' i. k- G' |, C4 t+ h* `3 {; ^
8 W6 j5 Z2 {/ g' s- N
6 }  I3 T/ r) t- N) O4 GCitation:
- k1 B8 r# `( h' L: PJ Clin Oncol 29: 2011 (suppl; abstr 10517)

" B0 S+ X$ U7 n0 B
, Q! P; T: ~& W/ _1 y4 H! kAuthor(s):
J. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China

- Q; `; A2 `# O4 ]1 e5 N( d
: F8 `9 \: [( {
Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.

Abstract Disclosures

0 N  W' P- D; N$ a. ]Abstract:
* T% m, ?2 X( U( B5 B, M  [1 E# o
; E3 z" w; }; w' n, {: n
$ @3 b2 S+ S( E: ~Background: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.


$ k+ j/ h5 j" V! q- {" K9 G

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

                               
登录/注册后可看大图

9 B) B1 S! h* V) s7 g5 B6 R" N7 p没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

                               
登录/注册后可看大图

易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
ALK一个指标医院要900多 ...

平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？
& r9 J3 U, f1 a! S: Q/ x+ [
现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊